BWA
ELV icon

Brave Warrior Advisors’s Elevance Health ELV Stock Holding History

Brave Warrior Advisors’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$378M Sell
976,885
-145,423
-13% -$53.9M 8.23% 4
2026
Q1 		$329M Sell
1,122,308
-129,495
-10% -$42.6M 8.13% 4
2025
Q4 		$439M Sell
1,251,803
-582,199
-32% -$197M 10.28% 3
2025
Q3 		$593M Buy
1,834,002
+724,349
+65% +$225M 13.76% 1
2025
Q2 		$432M Sell
1,109,653
-467,917
-30% -$188M 9.89% 3
2025
Q1 		$686M Sell
1,577,570
-52,407
-3% -$21M 15.72% 1
2024
Q4 		$601M Sell
1,629,977
-11,436
-0.7% -$4.79M 14.96% 1
2024
Q3 		$854M Buy
1,641,413
+8,286
+0.5% +$4.43M 17.71% 1
2024
Q2 		$885M Sell
1,633,127
-12,710
-0.8% -$6.72M 19.61% 1
2024
Q1 		$853M Sell
1,645,837
-110,816
-6% -$55.1M 17.85% 1
2023
Q4 		$828M Buy
1,756,653
+129,055
+8% +$59.7M 19.76% 1
2023
Q3 		$709M Buy
1,627,598
+306,326
+23% +$139M 17.69% 1
2023
Q2 		$587M Buy
1,321,272
+236,504
+22% +$109M 15.51% 2
2023
Q1 		$499M Buy
1,084,768
+212,353
+24% +$101M 15.43% 2
2022
Q4 		$448M Sell
872,415
-317,456
-27% -$161M 14.1% 2
2022
Q3 		$540M Sell
1,189,871
-21,405
-2% -$10.2M 18.68% 1
2022
Q2 		$585M Sell
1,211,276
-141,973
-10% -$70.2M 20.07% 1
2022
Q1 		$665M Sell
1,353,249
-12,536
-0.9% -$5.73M 19.61% 1
2021
Q4 		$633M Sell
1,365,785
-5,477
-0.4% -$2.3M 20.17% 1
2021
Q3 		$511M Buy
1,371,262
+225,846
+20% +$85.8M 17.9% 1
2021
Q2 		$437M Sell
1,145,416
-18,313
-2% -$7M 15.01% 1
2021
Q1 		$418M Buy
1,163,729
+392,594
+51% +$126M 13.64% 1
2020
Q4 		$248M Buy
771,135
+7,208
+0.9% +$2.21M 9.11% 5
2020
Q3 		$205M Sell
763,927
-7,541
-1% -$2.03M 9.16% 4
2020
Q2 		$203M Sell
771,468
-103,999
-12% -$27.7M 10.09% 3
2020
Q1 		$199M Buy
875,467
+247,815
+39% +$67.5M 11.44% 3
2019
Q4 		$190M Sell
627,652
-10,745
-2% -$2.96M 10.02% 5
2019
Q3 		$153M Buy
+638,397
New +$175M 8.18% 5

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Brave Warrior Advisors's ELV Position: Q2 2026 in Review

Brave Warrior Advisors reduced its Elevance Health (ELV) stake by 13% in Q2 2026, selling an estimated $53.9M and leaving 976,885 shares worth $378M. The position accounts for 8.23% of the portfolio, ranked #4.

Brave Warrior Advisors first reported a position in ELV in Q3 2019 and has held it in 28 quarters since. The position peaked at $885M in Q2 2024. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Brave Warrior Advisors held 976,885 shares of Elevance Health worth $378M as of Q2 2026.
  • Brave Warrior Advisors sold 145,423 Elevance Health shares in Q2 2026, an estimated $53.9M.
  • Elevance Health made up 8.23% of Brave Warrior Advisors's portfolio in Q2 2026, its #4 holding.
  • Brave Warrior Advisors first reported a position in Elevance Health in Q3 2019 and has held it in 28 quarters since.
  • Brave Warrior Advisors's Elevance Health position peaked at $885M in Q2 2024.
  • 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Brave Warrior Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.